vs
Foghorn Therapeutics Inc.（FHTX）与Rocky Mountain Chocolate Factory, Inc.（RMCF）财务数据对比。点击上方公司名可切换其他公司
Foghorn Therapeutics Inc.的季度营收约是Rocky Mountain Chocolate Factory, Inc.的1.2倍（$9.2M vs $7.5M），Rocky Mountain Chocolate Factory, Inc.净利率更高（-2.1% vs -234.3%，领先232.2%），Foghorn Therapeutics Inc.同比增速更快（223.8% vs -4.4%），过去两年Foghorn Therapeutics Inc.的营收复合增速更高（35.3% vs 1.9%）
Foghorn Therapeutics是一家临床阶段生物技术企业，专注于开发靶向染色质调控系统的创新疗法，用于治疗多种癌症及其他严重疾病，目前推进多款靶向候选药物管线，通过自主研发与战略合作服务全球患者群体。
落基山巧克力厂是美国知名巧克力企业，同时开展国际特许经营业务，集糖果生产与零售运营于一体，总部位于美国科罗拉多州杜兰戈，除美国本土门店外，在巴拿马、菲律宾也设有经营网点。
FHTX vs RMCF — 直观对比
营收规模更大
FHTX
是对方的1.2倍
$7.5M
营收增速更快
FHTX
高出228.2%
-4.4%
净利率更高
RMCF
高出232.2%
-234.3%
两年增速更快
FHTX
近两年复合增速
1.9%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $9.2M | $7.5M |
| 净利润 | $-21.7M | $-155.0K |
| 毛利率 | — | 34.0% |
| 营业利润率 | -258.2% | 1.1% |
| 净利率 | -234.3% | -2.1% |
| 营收同比 | 223.8% | -4.4% |
| 净利润同比 | -11.1% | 81.7% |
| 每股收益（稀释后） | $-0.35 | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FHTXRMCF
| Q4 25 | $9.2M | $7.5M | ||
| Q3 25 | $8.2M | $6.8M | ||
| Q2 25 | $7.6M | $6.4M | ||
| Q1 25 | $6.0M | $8.9M | ||
| Q4 24 | $2.9M | $7.9M | ||
| Q3 24 | $7.8M | $6.4M | ||
| Q2 24 | $6.9M | $6.4M | ||
| Q1 24 | $5.0M | $7.3M |
净利润FHTXRMCF
| Q4 25 | $-21.7M | $-155.0K | ||
| Q3 25 | $-15.8M | $-662.0K | ||
| Q2 25 | $-17.9M | $-324.0K | ||
| Q1 25 | $-18.8M | $-2.9M | ||
| Q4 24 | $-19.5M | $-847.0K | ||
| Q3 24 | $-19.1M | $-722.0K | ||
| Q2 24 | $-23.0M | $-1.7M | ||
| Q1 24 | $-25.0M | $-1.6M |
毛利率FHTXRMCF
| Q4 25 | — | 34.0% | ||
| Q3 25 | — | 23.6% | ||
| Q2 25 | — | 31.1% | ||
| Q1 25 | — | 10.8% | ||
| Q4 24 | — | 23.4% | ||
| Q3 24 | — | 31.8% | ||
| Q2 24 | — | 12.8% | ||
| Q1 24 | — | 24.3% |
营业利润率FHTXRMCF
| Q4 25 | -258.2% | 1.1% | ||
| Q3 25 | -226.9% | -7.0% | ||
| Q2 25 | -279.2% | -2.3% | ||
| Q1 25 | -385.0% | -30.3% | ||
| Q4 24 | -840.5% | -8.9% | ||
| Q3 24 | -305.5% | -14.3% | ||
| Q2 24 | -386.6% | -25.4% | ||
| Q1 24 | -558.3% | -21.7% |
净利率FHTXRMCF
| Q4 25 | -234.3% | -2.1% | ||
| Q3 25 | -194.4% | -9.7% | ||
| Q2 25 | -237.3% | -5.1% | ||
| Q1 25 | -316.4% | -32.5% | ||
| Q4 24 | -682.9% | -10.7% | ||
| Q3 24 | -244.9% | -11.3% | ||
| Q2 24 | -333.6% | -25.9% | ||
| Q1 24 | -495.4% | -21.9% |
每股收益（稀释后）FHTXRMCF
| Q4 25 | $-0.35 | $-0.02 | ||
| Q3 25 | $-0.25 | $-0.09 | ||
| Q2 25 | $-0.28 | $-0.04 | ||
| Q1 25 | $-0.30 | $-0.38 | ||
| Q4 24 | $-0.23 | $-0.11 | ||
| Q3 24 | $-0.31 | $-0.11 | ||
| Q2 24 | $-0.45 | $-0.26 | ||
| Q1 24 | $-0.59 | $-0.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $80.9M | $641.0K |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-108.5M | $6.0M |
| 总资产 | $198.1M | $20.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FHTXRMCF
| Q4 25 | $80.9M | $641.0K | ||
| Q3 25 | $89.3M | $2.0M | ||
| Q2 25 | $72.6M | $893.0K | ||
| Q1 25 | $61.0M | $720.0K | ||
| Q4 24 | $55.5M | $1.1M | ||
| Q3 24 | $57.7M | $973.0K | ||
| Q2 24 | $138.9M | $637.0K | ||
| Q1 24 | $79.3M | $2.1M |
股东权益FHTXRMCF
| Q4 25 | $-108.5M | $6.0M | ||
| Q3 25 | $-89.7M | $6.1M | ||
| Q2 25 | $-76.7M | $6.7M | ||
| Q1 25 | $-61.7M | $7.0M | ||
| Q4 24 | $-45.5M | $9.8M | ||
| Q3 24 | $-28.3M | $10.5M | ||
| Q2 24 | $-14.3M | $9.0M | ||
| Q1 24 | $-97.5M | $10.6M |
总资产FHTXRMCF
| Q4 25 | $198.1M | $20.7M | ||
| Q3 25 | $205.0M | $22.3M | ||
| Q2 25 | $226.2M | $20.1M | ||
| Q1 25 | $258.7M | $21.2M | ||
| Q4 24 | $284.0M | $21.6M | ||
| Q3 24 | $308.4M | $21.1M | ||
| Q2 24 | $328.6M | $19.0M | ||
| Q1 24 | $255.0M | $20.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.3M | $-1.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-1.3M |
| 自由现金流率自由现金流/营收 | — | -16.9% |
| 资本支出强度资本支出/营收 | 0.0% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流FHTXRMCF
| Q4 25 | $-22.3M | $-1.2M | ||
| Q3 25 | $-18.9M | $-488.0K | ||
| Q2 25 | $-21.0M | $350.0K | ||
| Q1 25 | $-24.0M | $1.2M | ||
| Q4 24 | $-24.5M | $-2.1M | ||
| Q3 24 | $-21.0M | $-3.5M | ||
| Q2 24 | $-25.5M | $-2.2M | ||
| Q1 24 | $-29.3M | $129.0K |
自由现金流FHTXRMCF
| Q4 25 | — | $-1.3M | ||
| Q3 25 | — | $-544.0K | ||
| Q2 25 | $-21.0M | $182.0K | ||
| Q1 25 | $-24.0M | — | ||
| Q4 24 | $-25.0M | — | ||
| Q3 24 | $-21.3M | $-4.6M | ||
| Q2 24 | $-25.6M | $-2.6M | ||
| Q1 24 | $-29.4M | $-352.3K |
自由现金流率FHTXRMCF
| Q4 25 | — | -16.9% | ||
| Q3 25 | — | -8.0% | ||
| Q2 25 | -278.2% | 2.9% | ||
| Q1 25 | -403.2% | — | ||
| Q4 24 | -875.3% | — | ||
| Q3 24 | -273.0% | -72.6% | ||
| Q2 24 | -371.0% | -40.2% | ||
| Q1 24 | -583.1% | -4.9% |
资本支出强度FHTXRMCF
| Q4 25 | 0.0% | 0.5% | ||
| Q3 25 | 0.0% | 0.8% | ||
| Q2 25 | 0.3% | 2.6% | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 16.8% | — | ||
| Q3 24 | 4.0% | 17.5% | ||
| Q2 24 | 0.2% | 6.5% | ||
| Q1 24 | 2.0% | 6.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FHTX
暂无分部数据
RMCF
| Manufacturing | $5.9M | 78% |
| Transferred At Point In Time | $1.2M | 16% |
| Other | $414.0K | 5% |
